CD33 and primary biliary cholangitis: Another important finding of our study is that we examined the expression of hepatic CD11b+CD33+ MDSCs in liver biopsy of 24 patients with CHB, 18 with NAFLD, 13 with HCC, 16 with PBC, and 27 with AIH by immunofluorescence analysis.